Breast Cancer News and Research

Latest Breast Cancer News and Research

TechniScan becomes publicly traded company through reverse merger with Castillo

TechniScan, Inc. (OTCBB: TSNI) (“TechniScan” or the “Company”), a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, has become a publicly traded company through a reverse merger with and into Castillo, Inc., a Delaware corporation.

20 Oct 2009

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

Phase 3 data reported for the first time show that once every four week subcutaneous injections of SIMPONI(TM) (golimumab) resulted in significantly greater inhibition of structural damage compared with placebo plus methotrexate in patients with active rheumatoid arthritis (RA) and active psoriatic arthritis (PsA).

20 Oct 2009

Health Discovery Corporation granted additional patents for Recursive Feature Elimination using Support Vector Machines

Health Discovery Corporation is pleased to announce numerous additional issued patents and Notices of Allowance since its last press release describing its intellectual property portfolio. The Company now has a total of 37 issued patents, 4 Notices of Allowance and 30 pending patent applications.

20 Oct 2009

Highly educated women deal less well with psychological aspects of breast cancer

Well-educated women and those who live alone are emotionally the hardest hit by breast cancer, according to the findings of a new Australian study announced during October's Breast Cancer Awareness Month.

20 Oct 2009

PhRMA report says nearly 1,000 life-changing medicines for diseases affecting women in development

America's pharmaceutical research and biotechnology companies are working on nearly 1,000 life-changing medicines for diseases affecting women, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). The medicines are awaiting approval by the U.S. Food and Drug Administration or are in human clinical trials.

20 Oct 2009

Right combination of estrogen and SERM can reduce breast cancer risk

The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk, Yale researchers report in an abstract presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21.

20 Oct 2009

Walgreens, aVinci Media launch initiative for breast cancer awareness, raises more than $50,000

Walgreens and aVinci® Media have launched a very successful national initiative to raise vital funds and awareness for breast cancer research and support. On Oct. 7, Walgreens offered aVinci's My Personal Movie slideshow DVDs, which normally retail for $19.99, for only $1.

19 Oct 2009

24 Hour Data to support breast cancer awareness, to donate 5% of its October sales to NBCF

24 Hour Data today announced its support for Breast Cancer Awareness Month. In an effort to raise awareness about the importance of early detection of breast cancer, the Dallas-based company will donate 5% of its October sales to the National Breast Cancer Foundation, Inc. (NBCF).

19 Oct 2009

Philippines and Malaysian regulatory agencies approve Celsion’s Phase III Thermodox trial

Celsion Corporation announced today that it has received approval from the regulatory agencis in the Philippines and Malaysia for its Pivotal Phase III primary liver cancer Clinical Trial Application.

19 Oct 2009

Hologic opens new facility in Hong Kong

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the opening of its new Asia Pacific regional offices and the Hologic Asia Pacific Center for Health Sciences Education in Hong Kong.

From Hologic, Inc. 19 Oct 2009

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

New long-term data from two pivotal, Phase 3 clinical trials showed that patients with active rheumatoid arthritis (RA) receiving SIMPONI(TM) (golimumab) every four weeks achieved sustained improvements in signs and symptoms and physical function response through one year. These new data were presented today at the 2009 American College of Rheumatology (ACR) Annual Scientific Meeting.

19 Oct 2009

Amgen receives Complete Response Letter for the Biologic License Applications for Prolia from FDA

Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Applications (BLA) for Prolia(TM) (denosumab) in the treatment and prevention of postmenopausal osteoporosis.

19 Oct 2009

New decision-making tool offers breast reconstruction options post cancer surgery

A computer-based decision-making aid may make it possible for more women to have breast reconstruction after surgical treatment for cancer.

19 Oct 2009

Physical therapists can promote early diagnosis of breast cancer-related lymphedema

As breast cancer awareness month is observed during October, the American Physical Therapy Association (APTA) is hoping to shine a spotlight on lymphedema, a chronic, debilitating and often irreversible side effect of cancer treatment.

19 Oct 2009

Institute Curie Hospital in France adds another TomoTherapy radiation therapy system

TomoTherapy Incorporated announced today that the Institute Curie Hospital in France has purchased a second TomoTherapy® radiation therapy system, to support the increasing demand for intensity-modulated radiation therapy (IMRT). The Institute Curie Hospital has been treating cancer patients with TomoTherapy technology since March 2007, when it became the first hospital in France to adopt the technology.

19 Oct 2009

Qforma introduces new phase of its healthcare database

Patients diagnosed with breast cancer or depression who are seeking a medical expert in their own community to guide them through treatment now have a place to start. Qforma, an advanced analytics and predictive modeling company, today introduced the new phase of its first-of-its-kind healthcare database "Most Influential Doctors," or MID, presented by USA TODAY.

19 Oct 2009

China's SFDA approves Celsion’s global Phase III ThermoDox HEAT trial for treating liver cancer

Celsion Corporation announced today that it has received official approval from China’s State Food and Drug Administration (“SFDA”) for its Clinical Trial Application for ThermoDox that permits Celsion to include Chinese clinical trial sites in its Phase III ThermoDox HEAT trial for the treatment of primary liver cancer, also known as hepatocellular carcinoma (HCC).

15 Oct 2009

Access Pharmaceuticals' update on its European commercial launch of Mugard

ACCESS PHARMACEUTICALS, INC. today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy.

15 Oct 2009

ADI and CeTeCancer collaborate for research project

Radient Pharmaceuticals Corporation, a US-based pharmaceutical company, announced today it has entered into a collaboration agreement through its wholly owned subsidiary AMDL Diagnostics, Inc. (ADI) with CeTeCancer -- a Chilean-based research laboratory -- to validate the effectiveness of Radient Pharmaceuticals' Onko-Sure™ in vitro diagnostic (IVD) cancer test as an early detection and prevention test for lung cancer.

15 Oct 2009

Purina Cat Chow's initiative for breast cancer awareness

Purina® Cat Chow® understands the unique bond between an owner and their cat and the connection they share. Inspired by a cancer survivor’s touching story of the role her cat played during her battle with cancer, Purina Cat Chow began a partnership with Susan G. Komen for the Cure®. A recent Purina Cat Chow national survey of breast cancer survivors with cats underscores this connection by revealing 84 percent of respondents felt their cat had a calming effect during their battle with breast cancer and 76 percent of respondents received daily support from their cat during treatment.

15 Oct 2009

Breast Cancer News and Research

Latest Breast Cancer News and Research

TechniScan becomes publicly traded company through reverse merger with Castillo

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

Health Discovery Corporation granted additional patents for Recursive Feature Elimination using Support Vector Machines

Highly educated women deal less well with psychological aspects of breast cancer

PhRMA report says nearly 1,000 life-changing medicines for diseases affecting women in development

Right combination of estrogen and SERM can reduce breast cancer risk

Walgreens, aVinci Media launch initiative for breast cancer awareness, raises more than $50,000

24 Hour Data to support breast cancer awareness, to donate 5% of its October sales to NBCF

Philippines and Malaysian regulatory agencies approve Celsion’s Phase III Thermodox trial

Hologic opens new facility in Hong Kong

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

Amgen receives Complete Response Letter for the Biologic License Applications for Prolia from FDA

New decision-making tool offers breast reconstruction options post cancer surgery

Physical therapists can promote early diagnosis of breast cancer-related lymphedema

Institute Curie Hospital in France adds another TomoTherapy radiation therapy system

Qforma introduces new phase of its healthcare database

China's SFDA approves Celsion’s global Phase III ThermoDox HEAT trial for treating liver cancer

Access Pharmaceuticals' update on its European commercial launch of Mugard

ADI and CeTeCancer collaborate for research project

Purina Cat Chow's initiative for breast cancer awareness

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Breast Cancer News and Research

Latest Breast Cancer News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in